Canaccord Genuity⬆️the PT on $CORT to $130 was $78 and reiterated at a Buy rating after they recently had the opportunity to catch up with the management team at Corcept. Canaccord said it sees strong likelihood of relacorilant approval for Cushing's in 2025, they believe Ph3 ROSELLA data will impress in 1Q25, and CATALYST data will continue to drive Cushing's franchise. Canaccord additionally said in its note to investors: "With much being delivered both clinically and on the revenue front in 2024, we believe 2025 is on track to be a robust year as well. With 4Q and FY2024 earnings likely to be released at the end of February (using last year as a guide), we have taken this opportunity to complete some model maintenance and put more thought into our out-year Cushing's franchise estimates. The result of our model updates results in our 12-month price target increasing to $130 from $78."

$TSLA $ENVX well this is a first from Google’s AI generator. My jaw is on the floor. @eenLien @RocketPenguin75 @Foldnow1984 @2percentisfair @mcinnes_danny @amitisinvesting @jmalchow @AlderLaneEggs

Oh, no. $PLTR

We remain bullish $CORT CORT is experiencing strong growth while remaining reasonably priced. Our cumulative return for this stock since portfolio's inception is 80% (in less than 8 months).

Los Angeles has gone Mad Max. Anyone still defending Karen Bass?

The $RILY fraud is massive with Billions of dollars in losses from investor victims. The company is also insolvent but refuses to issue financials—instead has gone dark amidst masse undisclosed employee departures @cbz @JerryGrisko

1/ Let’s talk about collapse. Fires rage in Los Angeles, and no one can put them out—a clear symbol of a civilization unable to solve even its most basic problems. Joseph A. Tainter's "The Collapse of Complex Societies" provides a framework to understand why this happens.

I'm long $SLS SELLAS Life Sciences via options (3:1 strap straddle). Catalyst: their press conference on 8th January 2025. Positive results of their pivotal phase 3 trial REGAL?